Insulin Resistance and Sex Hormones: The Metabolic-Endocrine Crossroads

Insulin and sex hormones are locked in a relationship that most people never think about until something goes wrong. Research published in Diabetes Care demonstrated that low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. But the connection runs deeper than association. Insulin resistance actively suppresses testosterone production in men while driving androgen excess in women, making it a central node in sex-hormone disruption across both sexes.

In women, the mechanism is well characterized through polycystic ovary syndrome. Excessive insulin enhances the stimulating effects of LH on androgen production in ovarian theca cells, while simultaneously decreasing sex hormone-binding globulin, amplifying the androgenic effect. About 70% of women with PCOS have insulin resistance, and total testosterone correlates significantly with insulin resistance severity. This creates a vicious cycle where hyperinsulinemia drives hyperandrogenism, which in turn worsens metabolic dysfunction.

In men, the pattern inverts but is equally damaging. Insulin resistance suppresses gonadotropin-releasing hormone and LH secretion, reducing testicular testosterone output. Low testosterone then promotes visceral fat accumulation and further insulin resistance, completing the feedback loop. The relationship is sexually dimorphic but metabolically unified: disrupted insulin signaling corrupts sex hormone regulation regardless of sex.

This interconnection explains why metabolic and hormonal conditions so frequently co-occur, and why treating one without addressing the other produces incomplete results.

The Tracking Connection

Kairos™ tracks metabolic and hormonal markers in the same system because they are part of the same system. By monitoring fasting glucose, HbA1c, testosterone, SHBG, and insulin sensitivity indicators alongside body composition over time, Kairos reveals whether hormonal changes are metabolically driven, allowing providers to target the root cause rather than chasing isolated lab values.